Prescriber's Corner

Palbociclib: A New Option for Front-Line Treatment of Metastatic, Hormone Receptor–Positive, HER2-Negative Breast Cancer

Harmony J. Bowles, PharmD, and Kathryn L. Clarke, NP-C

University of Arizona Cancer Center, Tucson, Arizona

Harmony J. Bowles, PharmD, University of Arizona Cancer Center, 3838 N. Campbell Avenue, Tucson, AZ 85719. E-mail: harmony.bowles@bannerhealth.com


doi: 10.6004/jadpro.6.6.6 | © 2015 Harborside Press®


  



For access to the full length article, please sign in.

Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2016 Harborside Press, LLC All rights reserved.                Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact
Copyright Notice/Disclaimer
Bot trap - Don't go here